Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nifurtimox response of Trypanosoma cruzi isolates from an outbreak of Chagas disease in Caracas, Venezuela.

Journal of vector borne diseases - 1 Jan 2000

Munoz-Calderon Arturo, Díaz-Bello Zoraida, Ramírez José Luis, Noya Oscar, de Noya Belkisyolé Alarcón

Abstract excerpt

BACKGROUND & OBJECTIVES: In Venezuela, Chagas disease (ChD) is considered a serious health problem, with about 6 million people at risk; and acute outbreaks due to oral transmission of Chagas Disease (OChD) are becoming increasingly important. In 2007 there was a major outbreak of OChD and although patients from this episode were treated with nifurtimox (Lampit®-Bayer), about 70% therapeutic failure was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chagas Disease
Share to Disease Outbreaks

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance

Share to Inhibitory Concentration 50

Share to Treatment Failure

Share to Trypanocidal Agents

Share to Trypanosoma cruzi

Share to Venezuela

Source

Identifiers

PMID: 32655073
DOI: 10.4103/0972-9062.289397

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nifurtimox response of Trypanosoma cruzi isolates from an outbreak of Chagas disease in Caracas, Venezuela.PMID 32655073Read ↗

Genetic Characterization of Trypanosoma cruzi I Populations from an Oral Chagas Disease Outbreak in Venezuela: Natural Resistance to Nitroheterocyclic Drugs.Semantic proximity Read ↗

In vitro susceptibility to benznidazole, nifurtimox and posaconazole of Trypanosoma cruzi isolates from ParaguaySemantic proximity Read ↗

Phenotypic diversity and drug susceptibility of Trypanosoma cruzi TcV clinical isolates.Semantic proximity Read ↗

In vitro susceptibility of Trypanosoma cruzi discrete typing units (DTUs) to benznidazole: A systematic review and meta-analysis.Semantic proximity Read ↗

Acute Chagas outbreaks: molecular and biological features of Trypanosoma cruzi isolates, and clinical aspects of acute cases in Santander, Colombia.Semantic proximity Read ↗

Evaluation of Nifurtimox Treatment of Chronic Chagas Disease by Means of Several Parasitological MethodsSemantic proximity Read ↗

Molecular Characterization of Four Mexican Isolates of Trypanosoma cruzi and Their Profile Susceptibility to Nifurtimox.Semantic proximity Read ↗

In Vitro Benznidazole and Nifurtimox Susceptibility Profile of Trypanosoma cruzi Strains Belonging to Discrete Typing Units TcI, TcII, and TcVSemantic proximity Read ↗

Trypanosoma cruzi DTU diversity, benznidazole response, and clinical manifestations of Chagas disease: a seventeen-year systematic review and meta-analysis.Semantic proximity Read ↗

Lack of correlation between in vitro susceptibility to Benznidazole and phylogenetic diversity of Trypanosoma cruzi, the agent of Chagas disease.Semantic proximity Read ↗

Sodium Diethyldithiocarbamate antiparasitic activity against different <i>Trypanosoma cruzi</i> strains: Insights of its biological activitySemantic proximity Read ↗

In Vitro Benznidazole and Nifurtimox Susceptibility Profile of <em>Trypanosoma cruzi</em> Strains Belonging to Discrete Typing Units TcI, TcII and TcVSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.